Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Oral and craniofacial manifestations of multiple sclerosis: implications for the oral health care provider.
Vitamin D levels and risk of multiple sclerosis in patients with clinically isolated syndromes.
New Microparticle Secondary Progressive MS Therapy Dosing Tested In Australian Clinical Trial
T Cell Epitope Mapping of JC Polyoma Virus-Encoded Proteome Reveals Reduced T Cell Responses in HLA-DRB1*04:01+ Donors.
Expansion of Functional Human Mucosal-Associated Invariant T Cells via Reprogramming to Pluripotency and Redifferentiation.
Fingolimod in a patient with heart failure on the background of pulmonary arterial hypertension and coronary artery disease.
Uveitis as a prognostic factor in multiple sclerosis.
Myelination at a glance.
2-BFI ameliorates EAE-induced mouse spinal cord damage: Effective therapeutic time window and possible mechanisms.
Comparison of Standard 1.5 T vs. 3 T Optimized Protocols in Patients Treated with Glatiramer Acetate. A Serial MRI Pilot Study.
Expanded Disability Status Scale (EDSS) estimation in multiple sclerosis from posturographic data.
Markers of oxidative stress in plasma and saliva in patients with multiple sclerosis.
Curcumin Serves as a Human Kv1.3 Blocker to Inhibit Effector Memory T Lymphocyte Activities.
Mechanics in Neuronal Development and Repair.
Central nervous system demyelinating diseases and recombinant hepatitis B vaccination: a critical systematic review of scientific production.
Current status of myelin replacement therapies in multiple sclerosis.
[Importance and treatment of spasticity in multiple sclerosis : Results of the MOVE 1 study].
Ampyra for Optic Neuritis in MS
A case of acute disseminated encephalomyelitis associated with hepatitis C virus infection.
Merck Serono and Opexa Therapeutics Enter into Option and License Agreement for Development of Tcelna™ (imilecleucel-T) for Treatment of Multiple Sclerosis
Experiences of functional electrical stimulation (FES) and ankle foot orthoses (AFOs) for foot-drop in people with multiple sclerosis.
Japanese cases of neuromyelitis optica spectrum disorder associated with myasthenia gravis and a review of the literature.
"Disease modifying nutricals" for multiple sclerosis.
Axonal loss in non-optic neuritis eyes of patients with multiple sclerosis linked to delayed visual evoked potential.
Self-reported health promotion and disability progression in multiple sclerosis.

Pages